Search

everythinglearnresearchcommunity

for

Search:↓

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Cepharanthine shows promise as a natural anticancer treatment.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

A truncated protein linked to breast cancer may change cell adhesion.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Tryptanthrin effectively suppresses non-melanoma skin cancer and is safe for normal skin.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Keratin 15 expression in skin cells is regulated by two mechanisms involving PKC/AP-1 and FOXM1.

Blocking YAP/TAZ could be a new way to treat skin cancer.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Vitexin shows promise as a cancer treatment by affecting key cellular processes and pathways.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.